Andorra Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on January 8, 2026

Jan. 8, 2026

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

GlobeNewswire

Jan. 8, 2026

Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition

GlobeNewswire

Jan. 8, 2026

SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer

GlobeNewswire

Jan. 8, 2026

AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals

GlobeNewswire

Jan. 8, 2026

Cellectis Announces 2026 Strategy and Catalysts

GlobeNewswire

Jan. 8, 2026

World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months

GlobeNewswire

Jan. 8, 2026

AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals

GlobeNewswire

Jan. 8, 2026

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

GlobeNewswire

Jan. 8, 2026

Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

GlobeNewswire

Jan. 8, 2026

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

GlobeNewswire

Jan. 8, 2026

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

GlobeNewswire

Jan. 8, 2026

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

GlobeNewswire

Jan. 8, 2026

ClinNEXUS Launches New Corporate Rebranding to Kick Off Attendance During Week of J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 8, 2026

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

GlobeNewswire

Jan. 8, 2026

Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 8, 2026

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

GlobeNewswire

Jan. 8, 2026

Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)

GlobeNewswire

Jan. 8, 2026

Syneos Health Appoints Simon Bartle as Chief Human Resources Officer

GlobeNewswire

Jan. 8, 2026

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech

GlobeNewswire

Jan. 8, 2026

MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

GlobeNewswire